Otorhinolaryngologic disease
MONDO:0024623Pathological processes of the ear, the nose, and the throat, also known as the ENT diseases.
Also known as: ear, nose and throat disorder, ear, nose or throat disorder, ear/nose/throat disease, otolaryngologic disorder, otorhinolaryngologic disease, ENT disease, ENT diseases, disease, ENT
1122 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New pill-chemo combo takes on hard-to-treat cancers
Disease control Not yet recruitingThis study tests a new drug called SX-682 (a tablet) combined with the chemotherapy docetaxel in people whose head/neck, salivary gland, or prostate cancer has spread or returned after treatment. The goal is to find the right dose and see if the combination shrinks tumors. About …
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New combo aims to tame HPV throat cancer with fewer side effects
Disease control Not yet recruitingThis early-phase trial tests whether a new drug (ATRN-119) combined with a single, precise dose of radiation to the neck can safely and effectively treat early-stage HPV-positive throat cancer before surgery. About 35 participants will take the drug daily for 10 days and receive …
Phase: PHASE1, PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New pastille could change head and neck cancer treatment
Disease control Not yet recruitingThis large Phase 3 trial is testing a new drug called APG-157, given as a pastille that dissolves in the mouth, for people with advanced head and neck cancer. The study will see if adding APG-157 before and after standard treatments (surgery or chemoradiation) helps keep the canc…
Phase: PHASE3 • Sponsor: Aveta Biomics, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Promising drug cocktail aims to save voice boxes in throat cancer patients
Disease control Not yet recruitingThis phase II trial tests two drugs—becotatug vedotin and pucotenlimab—given before surgery to people with advanced hypopharyngeal cancer. The goal is to shrink tumors enough to improve surgical outcomes and possibly preserve the voice box. About 52 participants will receive thre…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Tailored radiation aims to shrink tumors, spare healthy tissue in nasopharyngeal cancer
Disease control Not yet recruitingThis phase 3 trial tests whether a personalized radiation plan, which expands the treatment area based on each patient's tumor margins, can control nasopharyngeal cancer as well as the standard approach. The study includes 568 adults with newly diagnosed, non-metastatic disease. …
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drill aims to make cochlear implants quicker and gentler
Disease control Not yet recruitingThis early study tests a new surgical device called the Microtable® Stereotactic System for cochlear implants. The device uses a custom-made frame to guide a drill precisely to the inner ear, potentially making surgery faster, less painful, and better at preserving taste. The stu…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Immunotherapy duo aims to shrink nasopharyngeal tumors before standard treatment
Disease control Not yet recruitingThis trial tests whether adding the immunotherapy drugs cemiplimab (with or without fianlimab) to standard chemotherapy before chemoradiation can improve outcomes for people with advanced nasopharyngeal cancer. About 60 adults with non-metastatic, EBV-positive nasopharyngeal carc…
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study tests tezepelumab for chronic sinusitis sufferers
Disease control Not yet recruitingThis study follows 200 adults with severe chronic sinusitis and nasal polyps who are starting tezepelumab as part of their routine care. Researchers will track changes in symptoms and quality of life over up to two years using patient questionnaires. The goal is to see how well t…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Blood test could guide cancer treatment, reducing side effects
Disease control Not yet recruitingThis study tests whether a blood test that detects HPV DNA can help doctors choose the right treatment for people with HPV-positive oropharyngeal cancer. About 116 participants with stage I to III cancer will receive either the immunotherapy drug pembrolizumab (Keytruda) or stand…
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Stem cell nasal spray takes on sinusitis
Disease control Not yet recruitingThis study tests a new nasal spray for adults with chronic sinusitis. The spray turns into a gel inside the nose and releases three active ingredients: stem cell exosomes to help repair the nasal lining, an antihistamine to reduce inflammation, and an antiviral agent. The goal is…
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Triple-Action nasal spray could ease chronic sinusitis
Disease control Not yet recruitingThis early-stage trial tests a nasal spray for adults with chronic sinusitis (without polyps). The spray contains stem cell exosomes to heal the nose lining, an antibiotic to kill bacteria, and an enzyme to break up thick mucus. 108 participants will use the spray twice daily for…
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital of Xinxiang Medical College • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug aims to stop aggressive nose cancer from coming back
Disease control Not yet recruitingThis phase 2 trial tests whether the drug becotatug vedotin can prevent cancer from returning in 140 patients with high-risk nasopharyngeal carcinoma who have completed standard chemo-radiation. Participants are randomly assigned to receive the drug or standard care. The main goa…
Phase: PHASE2 • Sponsor: Kai Hu • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New Vaccine-Drug combo aims to tame HPV throat cancer with less radiation
Disease control Not yet recruitingThis study tests a new treatment plan for people with HPV-positive oropharyngeal cancer (a type of throat cancer linked to HPV). The plan combines an immune-boosting drug (nogapendekin alfa inbakicept), a vaccine targeting HPV, chemotherapy, and a lower dose of radiation. The goa…
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Ancient gut therapy takes on allergies in new clinical trial
Disease control Not yet recruitingThis study tests whether an Ayurvedic treatment that targets digestion and gut health can reduce allergy symptoms and immune markers in people with allergic rhinitis (hay fever). 104 adults aged 18-40 with confirmed allergies will receive either the Ayurvedic treatment plus stand…
Phase: NA • Sponsor: Amrita Vishwa Vidyapeetham • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New ear tube robot could make surgery quicker and safer for kids
Disease control Not yet recruitingThis study tests a new handheld device called CLiKX that helps doctors place ear tubes in children and adults with chronic ear infections or fluid buildup. The device uses sensors and controlled force to make the procedure more precise. Researchers will check if the tube is place…
Phase: NA • Sponsor: ClinQure, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New trial aims to stop oral lesions from turning into cancer
Disease control Not yet recruitingThis study looks at the best way to treat people with p53-mutant oral dysplasia (abnormal cells in the mouth) and early-stage oral cancer. About 636 adults will be placed into three groups based on their diagnosis and receive either monitoring, surgery, or surgery plus neck disse…
Phase: NA • Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a Pre-Surgery drug boost nasal polyp treatment?
Disease control Not yet recruitingThis study looks at whether taking the drug stapokibart for 4 weeks before sinus surgery helps adults with chronic nasal polyps more than surgery alone. About 48 participants will receive either the drug or a placebo before their operation and be followed for nearly a year. The g…
Phase: NA • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Promising drug cocktail aims to shrink aggressive nasal tumors before surgery
Disease control Not yet recruitingThis study tests whether giving a combination of anlotinib (a targeted therapy) and epirubicin (chemotherapy) before surgery can improve outcomes for people with advanced sinonasal adenoid cystic carcinoma, a rare and aggressive cancer of the nasal cavity and sinuses. About 76 pa…
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Triple therapy aims to shrink head and neck tumors before surgery
Disease control Not yet recruitingThis study tests a combination of an experimental drug (ficerafusp alfa), an immunotherapy (pembrolizumab), and targeted radiation before surgery for people with advanced head and neck cancer that is HPV-negative. About 45 participants will receive these treatments over several w…
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Tear duct showdown: probing or massage for babies?
Disease control Not yet recruitingThis study looks at 50 infants born with a blocked tear duct (a common condition causing watery eyes). It compares two treatments: early probing (a quick procedure to open the duct) and tear duct massage. The goal is to find which approach works best and when to do it, to help ba…
Phase: NA • Sponsor: Hany Mahmoud,MD • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New proton therapy trial aims to reduce side effects in nasopharyngeal cancer
Disease control Not yet recruitingThis Phase III trial will compare proton beam radiotherapy with standard photon radiotherapy in 504 patients with non-metastatic nasopharyngeal carcinoma. The goal is to see if proton therapy reduces toxic side effects and improves survival. Participants will be randomly assigned…
Phase: NA • Sponsor: Guangzhou Concord Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New cell therapy aims to boost hearing restoration in cochlear implant patients
Disease control Not yet recruitingThis early-stage trial tests a new cell therapy called Rincell-1 for adults with certain types of hearing loss who are getting a cochlear implant. The study will compare the safety and early effectiveness of receiving the cell therapy plus the implant versus the implant alone. Ab…
Phase: PHASE1, PHASE2 • Sponsor: Rinri Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Radiation-Free hope: study tests if surgery alone is enough for rare nasal cancer
Disease control Not yet recruitingThis study looks at whether patients with a rare nasal cancer (sinonasal adenoid cystic carcinoma) can safely avoid radiation after surgery if the tumor was completely removed. About 200 patients will choose either surgery alone or surgery plus radiation, and researchers will tra…
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New digital toolkit aims to transform care for millions with multiple chronic diseases
Disease control Not yet recruitingThis study is for adults aged 40 and older who have two or more chronic conditions like high blood pressure, diabetes, or depression. Researchers are testing a program that includes a digital decision-support system for doctors, telemedicine for specialist advice, and a mobile ap…
Phase: NA • Sponsor: Centre for Chronic Disease Control, India • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug cocktail aims to shrink oral tumors before surgery
Disease control Not yet recruitingThis phase 2 trial tests a combination of two drugs, XL-092 and pembrolizumab (Keytruda), given before surgery to people with a type of oral cancer that is HPV-negative and can be removed. The goal is to see if the drugs can shrink or eliminate the tumor before the operation. Abo…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New hope for head and neck cancer: which drug works best with radiation?
Disease control Not yet recruitingThis study compares two treatments for people with advanced head and neck cancer who cannot use the standard drug cisplatin. About 454 participants will receive either cetuximab (a targeted antibody) or a chemotherapy combo (carboplatin + paclitaxel) alongside precise radiation t…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for Hard-to-Treat nasopharyngeal cancer: ivonescimab trial launches
Disease control Not yet recruitingThis phase 2 trial is testing a drug called ivonescimab in 42 people with a type of head and neck cancer (nasopharyngeal carcinoma) that has stopped responding to standard immunotherapy and chemotherapy. The drug is given every 3 weeks by IV. Researchers will measure how many pat…
Phase: PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Oxygen chamber therapy put to the test for dozens of diseases
Disease control Not yet recruitingThis study will test hyperbaric oxygen therapy (HBOT) — breathing pure oxygen in a pressurized chamber — for over 30 conditions, including long COVID, Crohn's disease, frostbite, and multiple sclerosis. Researchers will track 100 patients to see if HBOT improves their quality of …
Phase: PHASE4 • Sponsor: Jay C. Buckey Jr. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Tailored diet plans during pregnancy show promise in cutting preterm birth and diabetes risk
Disease control Not yet recruitingThe ROOT study is testing a personalized nutrition program for pregnant women. Participants receive standard prenatal care plus customized diet and lifestyle plans based on their genes and nutrient levels. The goal is to see if this approach can lower the chances of preterm birth…
Phase: NA • Sponsor: GrowBaby Life Project • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Promising new combo aims to shrink returning throat tumors
Disease control Not yet recruitingThis study tests a new treatment for people whose nasopharyngeal cancer has come back and cannot be surgically removed. Participants will receive two cycles of a targeted drug (becotatug vedotin) plus an immunotherapy, followed by radiation and continued immunotherapy. The goal i…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug combo aims to stop advanced nose cancer from coming back
Disease control Not yet recruitingThis phase 3 trial tests whether adding an immunotherapy drug (PD-1 antibody) and a targeted therapy (anlotinib) to standard chemotherapy and radiation can help prevent cancer from returning in people with high-risk, advanced nasopharyngeal carcinoma. About 442 adults aged 18-65 …
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug duo aims to shrink oral cancers before surgery
Disease control Not yet recruitingThis study tests whether giving two drugs together before surgery can shrink advanced mouth or throat cancers. The drugs are becotatug vedotin and pucotenlimab. About 26 people with stage III or IVa cancer will take part. The goal is to see if the cancer nearly or completely disa…
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New triple combo aims to tackle Hard-to-Treat liver cancer
Disease control Not yet recruitingThis phase 2 trial tests a combination of two drugs (Benmelstobart and Anlotinib) plus targeted radiation (SBRT) in 29 adults with liver cancer that has spread to a few other spots and no longer responds to first-line treatment. The goal is to see if this triple therapy can slow …
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New combo therapy offers hope for hard-to-treat nose cancer
Disease control Not yet recruitingThis study tests a new treatment for people whose nose and throat cancer has returned and cannot be removed with surgery. The treatment combines an immunotherapy drug (PD-1 antibody) with two chemotherapy drugs, followed by targeted radiation. The goal is to see if this approach …
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug aims to tame severe allergies by lowering key antibody
Disease control Not yet recruitingThis early-stage study tests a new drug called cizutamig in about 20 adults with IgE-mediated allergies, including food allergies. The main goal is to see if the drug can safely lower IgE levels, which are antibodies that trigger allergic reactions. Researchers will also monitor …
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug cocktail aims to beat back aggressive throat cancer
Disease control Not yet recruitingThis Phase 3 trial tests whether adding a targeted drug (Becotatug Vedotin) to standard immunotherapy and chemo-radiation can improve outcomes for people with high-risk nasopharyngeal cancer. About 514 participants will be randomly assigned to receive either the new combo or stan…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Immunotherapy before surgery shows promise for oral cancer
Disease control Not yet recruitingThis study tests whether giving the immunotherapy drug nivolumab before surgery can shrink tumors in people with advanced oral cancer. About 60 adults with resectable oral squamous cell carcinoma will receive nivolumab, then have surgery. Researchers will also look for biomarkers…
Phase: PHASE2 • Sponsor: Prof. Lars Olaf Cardell • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Immune booster: donor NK cells aim to cut cancer recurrence
Disease control Not yet recruitingThis trial tests whether adding natural killer (NK) cells from healthy donors to standard chemoradiotherapy can reduce the risk of cancer returning in people with advanced nasopharyngeal cancer. The study has two phases: first, finding the safest dose of NK cells, then testing th…
Phase: PHASE1, PHASE2 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug aims to tame rare artery disease
Disease control Not yet recruitingThis phase 2 trial tests whether secukinumab, a drug that blocks IL-17A, can help people with active severe Takayasu arteritis achieve remission and stop taking steroids. About 52 participants will receive either secukinumab injections or standard care (like TNF inhibitors). The …
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New scan could spare throat cancer patients from unnecessary radiation side effects
Disease control Not yet recruitingThis study tests whether a special scan (SPECT-CT) can show which side of the neck needs radiation in people with oropharyngeal cancer. Currently, both sides are treated to prevent hidden cancer spread, but this causes more side effects. The trial will enroll 128 patients to see …
Phase: NA • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Video game tech could make oral cancer surgery more precise
Disease control Not yet recruitingThis study tests whether a mixed reality system, similar to video game technology, can help surgeons remove oral cancer and rebuild the area more accurately. Thirty people with oral cancer will be split into three groups: one using mixed reality, one using a virtual surgical guid…
Phase: NA • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
New triple therapy offers hope for hard-to-treat nose and throat cancer
Disease control Not yet recruitingThis study tests a combination of three drugs (chidamide, toripalimab, and anlotinib) in 52 adults with recurrent or metastatic nasopharyngeal carcinoma that has failed at least one prior treatment. The goal is to find the safest dose and see how many patients' tumors shrink. Par…
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New light treatment could fight oral cancer without surgery
Disease control Not yet recruitingThis study tests a low-cost approach to treat pre-cancerous and cancerous mouth lesions using a drug (5-ALA) that makes abnormal cells sensitive to light, followed by laser light delivered through a handheld device. The goal is to destroy these lesions without surgery. The trial …
Phase: PHASE2 • Sponsor: University of Massachusetts, Boston • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New dissolving film could tame dust mite allergies without shots
Disease control Not yet recruitingThis study tests a daily dissolving film placed under the tongue to treat dust mite allergic rhinitis (hay fever). About 250 adults in China will use either the active film or a placebo for one year. The goal is to see if the film reduces sneezing, stuffiness, and the need for re…
Phase: PHASE2 • Sponsor: Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Thin vs thick ear cartilage: which patch heals better?
Disease control Not yet recruitingThis study compares two types of cartilage grafts used to repair eardrum holes in adults. One graft is thin (0.5 mm) and the other is thick (1.8 mm). The goal is to see which one leads to better healing and hearing after six months. Thirty adults with long-standing eardrum perfor…
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New study tests best Follow-Up after surgery for oral cancer
Disease control Not yet recruitingThis study looks at people with advanced mouth or throat cancer who had chemotherapy and immunotherapy before surgery. After surgery, they will either get radiation, immunotherapy maintenance, or just be watched. The goal is to see which approach helps them live longer without th…
Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug combo aims to tame rare artery disease
Disease control Not yet recruitingThis study tests two new drugs, vunakizumab and ivarmacitinib, for people with active Takayasu arteritis (TAK), a rare disease that causes inflammation in large blood vessels. The trial will enroll 180 adults aged 18-70 whose disease is still active despite standard treatments. R…
Phase: PHASE4 • Sponsor: Chinese SLE Treatment And Research Group • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Could inhaled stem cell particles ease allergies and asthma?
Disease control Not yet recruitingThis early-phase trial is testing whether inhaling tiny particles from stem cells (called small extracellular vesicles) can safely help people with both allergic rhinitis and asthma. About 18 adults will receive either the active treatment or a placebo via nebulizer daily for two…
Phase: NA • Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New combo therapy aims to personalize throat cancer treatment
Disease control Not yet recruitingThis study tests a new approach for people with a certain type of throat cancer that is not low-risk. Participants first receive a combination of chemotherapy, immunotherapy, and a special type of radiation called lattice radiotherapy. Then, based on how much the tumor shrinks, t…
Phase: PHASE1, PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Triple threat: radiation, chemo, and immunotherapy before surgery shows promise for oral cancer
Disease control Not yet recruitingThis Phase 3 trial tests whether giving a short course of targeted radiation (SBRT) followed by chemotherapy and immunotherapy before surgery can improve outcomes for people with advanced oral or HPV-negative throat cancer. About 184 participants will be randomly assigned to rece…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug cocktail aims to fight Hard-to-Treat throat cancer
Disease control Not yet recruitingThis Phase 2 trial tests a combination of two drugs—Becotatug vedotin (a targeted therapy) and Pucotenlimab (an immunotherapy)—as a first treatment for people whose nasopharyngeal cancer has come back or spread. The study will enroll 30 adults and measure how long the cancer stay…
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Double implant hope for kids born without ears
Disease control Not yet recruitingThis study will test whether using two OSIA bone conduction implants (one on each side) helps children with severe ear malformations hear better in noisy places compared to using just one implant. Twelve children aged 7 to 17 who already use a bone conduction device will receive …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New combo aims to shrink head and neck tumors before surgery
Disease control Not yet recruitingThis phase 2 trial tests whether giving a combination of the immunotherapy drug camrelizumab and two chemotherapy drugs (paclitaxel and carboplatin) before surgery can improve outcomes for people with advanced oral cavity or larynx cancer. Fifty participants will receive three cy…
Phase: PHASE2 • Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Timing is everything: new trial seeks to boost cancer treatment by scheduling immunotherapy just right
Disease control Not yet recruitingThis Phase II trial tests whether giving the immunotherapy drug toripalimab on different days during chemotherapy can improve outcomes for people with advanced nasopharyngeal cancer. About 198 participants will receive standard chemotherapy plus toripalimab on Day 1, Day 5, or Da…
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug combo aims to shrink Hard-to-Treat throat cancer
Disease control Not yet recruitingThis phase 2 trial tests whether combining two drugs—scipibaimab and tislelizumab—can shrink tumors in people with recurrent or metastatic nasopharyngeal carcinoma that has worsened after first-line treatment. About 37 adults whose cancer has not responded to platinum chemotherap…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New gel could boost recovery after sinus surgery
Disease control Not yet recruitingThis phase 3 trial tests a gel containing povidone-iodine and budesonide that is placed inside the sinuses right after endoscopic sinus surgery. The goal is to see if it reduces inflammation and scarring better than a placebo gel. The study will involve 180 adults with chronic rh…
Phase: PHASE3 • Sponsor: Amin Javer • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New cocktail of drugs aims to stop High-Risk throat cancer in its tracks
Disease control Not yet recruitingThis Phase 3 trial will test whether adding anlotinib (a drug that cuts off tumor blood supply) to standard immunotherapy and chemotherapy with radiation can improve outcomes for 412 people with high-risk nasopharyngeal cancer. Participants will receive either the new combo or st…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could less immunotherapy be just as good for advanced nose cancer?
Disease control Not yet recruitingThis phase 3 trial will test whether a shorter course of the immunotherapy drug tislelizumab, combined with chemotherapy and radiation, works as well as a longer course for people with advanced nasopharyngeal cancer. About 418 participants will be randomly assigned to receive eit…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New radiation combo aims to shrink oral tumors before surgery
Disease control Not yet recruitingThis early-phase study tests a new type of radiation (lattice radiotherapy) given with chemotherapy and immunotherapy before surgery for oral cavity cancer. About 30 adults with advanced but removable tumors will receive different radiation doses to find the safest level. The goa…
Phase: PHASE1 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Booster shot may extend time between surgeries for RRP patients
Disease control Not yet recruitingThis study tests whether a one-time booster dose of the Gardasil-9 vaccine can lengthen the time between surgeries for adults with recurrent respiratory papillomatosis (RRP), a condition where non-cancerous growths keep coming back in the airway. Researchers will enroll 50 adults…
Phase: PHASE1, PHASE2 • Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New mRNA vaccine trial targets Virus-Linked cancers
Disease control Not yet recruitingThis early-phase trial tests an mRNA immunotherapy for people with tumors linked to the Epstein-Barr virus, such as nasopharyngeal cancer, gastric cancer, and lymphoma. The treatment aims to help the immune system recognize and attack cancer cells. Researchers will check safety a…
Phase: EARLY_PHASE1 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Nerve cut may supercharge tongue cancer treatment
Disease control Not yet recruitingThis phase II trial tests whether surgically cutting the lingual nerve (which controls tongue sensation) can make chemoimmunotherapy work better for people with advanced tongue cancer. 69 adults with stage T3/T4 tongue cancer will receive the nerve cut along with two cycles of ti…
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New combo therapy aims to control returning throat cancer
Disease control Not yet recruitingThis study tests a two-step treatment for people whose nasopharyngeal cancer has come back after initial treatment. First, patients receive a targeted drug (MRG003) plus an immunotherapy (PD-1) for six weeks. Then, they take a chemotherapy pill (capecitabine) with the immunothera…
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could a lung drug fix blood vessel damage in rare artery disease?
Disease control Not yet recruitingThis study tests whether adding pirfenidone, a drug used for lung and liver scarring, to standard treatment can improve blood vessel damage in people with Takayasu arteritis. About 92 adults aged 18-60 will receive either pirfenidone or a placebo for 6 months. The goal is to see …
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New ear surgery aims to restore hearing without large incisions
Disease control Not yet recruitingThis study tests a surgical procedure called endoscopic stapedotomy for people with otosclerosis, a condition that causes progressive hearing loss. Surgeons will use a tiny camera to place a small artificial device in the middle ear to improve sound transmission. The study will f…
Phase: NA • Sponsor: Sohag University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could skipping some neck radiation be just as effective?
Disease control Not yet recruitingThis study tests whether it is safe to skip radiation to a specific neck area (Level Va) in patients with a type of throat cancer called nasopharyngeal carcinoma. About 474 newly diagnosed patients without cancer spread will be randomly assigned to standard radiation or a reduced…
Phase: PHASE3 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug duo aims to shrink throat tumors before standard care
Disease control Not yet recruitingThis study tests whether giving two drugs (pembrolizumab and MRG-003) before standard chemoradiation can shrink tumors in people with advanced nasopharyngeal cancer linked to Epstein-Barr virus. About 35 adults with stage III-IVa disease will receive 3 cycles of the drug combo, t…
Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug aims to stop chemo side effect in nose and throat cancer
Disease control Not yet recruitingThis study tests whether the drug hetrombopag can prevent severe low platelet counts caused by chemotherapy in people with nasopharyngeal carcinoma. About 35 patients who already had low platelets during a previous chemo cycle will take hetrombopag tablets daily during their next…
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New combo therapy targets stubborn nasopharyngeal cancer in phase 3 trial
Disease control Not yet recruitingThis study tests whether adding chemotherapy to immunotherapy works better than immunotherapy alone for people with advanced nasopharyngeal cancer whose cancer did not fully respond to initial treatment. About 516 adults aged 18-65 with stage II-III disease will receive either th…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could virtual reality be the key to ending chronic dizziness?
Disease control Not yet recruitingThis study tests whether virtual reality (VR) therapy works better than standard balance exercises for people with long-term dizziness. Researchers will enroll 40 adults aged 18-70 who have had dizziness for over 3 months due to inner ear problems. Participants will receive eithe…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New ear cream trial aims to stop itchy fungal infections
Disease control Not yet recruitingThis study tests a cream called terbinafine hydrochloride for treating fungal ear infections (otomycosis). About 50 adults with symptoms like itching, pain, and discharge will have the cream applied in the ear every two days for two weeks. The goal is to see if the cream clears b…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could immunotherapy replace chemo in nasopharyngeal cancer?
Disease control Not yet recruitingThis phase III trial tests whether adding the immunotherapy drug serplulimab to standard induction chemotherapy can allow patients with advanced nasopharyngeal cancer to skip concurrent chemotherapy during radiation. The study plans to enroll 456 adults aged 18-65 with stage II-I…
Phase: PHASE3 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 26, 2026 18:11 UTC
-
New study aims to find best surgery for babies born with blocked nose
Disease control Not yet recruitingThis study compares two surgical techniques for infants born with choanal atresia, a condition where the nasal passages are blocked. Thirty infants up to 6 years old will receive either a puncture with mitomycin C or a flap technique. The goal is to see which method keeps the air…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 26, 2026 17:03 UTC
-
New combo aims to wipe out returning nose cancer with chemo, immunotherapy, and surgery
Disease control Not yet recruitingThis phase II trial tests whether giving pembrolizumab (an immunotherapy) plus chemotherapy before surgery, followed by maintenance pembrolizumab, can improve outcomes for people with locally recurrent nasopharyngeal carcinoma. About 53 participants will receive up to 6 cycles of…
Phase: PHASE2 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 26, 2026 13:57 UTC
-
Can a Blood-Derived gel help you smell again?
Disease control Not yet recruitingThis study tests whether a person's own platelet-rich plasma (PRP) can improve smell when placed in the nose on a gel sponge versus being injected. Sixty adults with smell loss lasting over three months will receive one treatment and then do smell training for three months. Resea…
Phase: PHASE3 • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Disease control
Last updated Jun 26, 2026 12:41 UTC
-
New Total-Body PET scanner could revolutionize vasculitis diagnosis
Diagnosis Not yet recruitingThis study will test a new type of PET/CT scanner, called Long-Axial Field-of-View (LAFOV), to see if it can provide clearer images of blood vessel inflammation in people with large vessel vasculitis (LVV). The scanner is more sensitive and can image the whole body faster, potent…
Phase: NA • Sponsor: Imperial College London • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
AI tool aims to cut allergy misdiagnosis in primary care
Diagnosis Not yet recruitingThis study tests whether AI-powered decision trees can help general practitioners better diagnose and manage allergies. About 600 patients with suspected allergies will be enrolled, and doctors will use an app that suggests next steps based on symptoms. The goal is to see if this…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Blood test could spot hidden throat cancers before symptoms start
Diagnosis Not yet recruitingThis study aims to see if a simple blood test can find HPV-related oropharyngeal cancer early in men aged 50 and older who have no symptoms. Researchers will check blood for two markers of HPV and then follow up with those who test positive to find and treat any tumors. If succes…
Phase: NA • Sponsor: UNICANCER • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
AI-Powered endoscopy aims to spot head and neck cancer earlier
Diagnosis Not yet recruitingThis study will test artificial intelligence algorithms that analyze video from routine endoscopies of the head and neck. The AI will try to detect, classify (benign vs. malignant), and outline lesions, comparing its performance to doctors and lab results. About 283 adults with s…
Sponsor: Istituto Italiano di Tecnologia • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
AI could spot mouth cancer early from a simple photo
Diagnosis Not yet recruitingThis study will collect thousands of photos of mouth lesions from patients seen over 50 years at a French hospital. Experts will review each photo to confirm the diagnosis. Researchers will then use these images and patient data to train an AI system to automatically identify can…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
Laser scope aims to spot ear fluid better than standard tools
Diagnosis Not yet recruitingThis study tests a new laser otoscope to see if it helps doctors find fluid behind the eardrum in children. About 150 kids already scheduled for ear tube surgery will get both a laser and a standard white-light ear exam. The results will be compared to what the surgeon finds duri…
Sponsor: MSTATT LLC • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
Can an ankle test diagnose a hearing disorder?
Diagnosis Not yet recruitingThis study aims to see if a simple vibration test at the ankle can identify patients with superior canal dehiscence syndrome (SCDS), a condition where a thin bone in the ear causes hearing of internal body sounds or pulsatile tinnitus. Researchers will test 30 adults with these s…
Phase: NA • Sponsor: Region Stockholm • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Gamified training and AI aim to sharpen ear infection diagnoses
Diagnosis Not yet recruitingThis study tests whether a gamified training program for doctors, plus an AI tool that analyzes ear drum images, can improve the accuracy of diagnosing ear infections (otitis media). About 200 patients with ear symptoms will be seen by doctors who either received the training or …
Phase: NA • Sponsor: Vastra Gotaland Region • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
AR glasses may revolutionize vertigo diagnosis
Diagnosis Not yet recruitingThis study tests whether wearable augmented reality (AR) glasses can diagnose vertigo as accurately as standard eye-movement exams. About 200 adults with vertigo will try both methods during one visit. If successful, AR glasses could make vertigo assessment faster and more access…
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
AI vs. doctors: can a phone app diagnose ear infections in kids?
Diagnosis Not yet recruitingThis study tests whether a smartphone algorithm (Glimpse) can accurately diagnose ear infections in children aged 6 months to 6 years. Parents and doctors will take videos of the child's ear, and the AI's diagnosis will be compared to that of an ear specialist. The goal is to see…
Sponsor: Glimpse Diagnostics, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Dust mite allergy test gets a tune-up in new study
Diagnosis Not yet recruitingThis study aims to find the best concentration of Blomia tropicalis (a type of dust mite) extract for allergy skin testing. About 30 adults with known dust mite allergies will receive small pricks with different extract strengths to see which causes a reaction similar to a standa…
Phase: NA • Sponsor: Inmunotek S.L. • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
Can light be the new shield against radiation mouth sores?
Prevention Not yet recruitingThis pilot study tests two light therapy devices—one placed inside the mouth and one outside—to prevent and treat painful mouth sores caused by radiation therapy. Sixty adults with oral cavity or oropharynx cancer will receive light sessions twice a week for prevention, then thre…
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Prevention
Last updated Jun 27, 2026 13:02 UTC
-
Simple scope procedure may prevent radiation damage in recurrent nose cancer
Prevention Not yet recruitingThis study tests whether removing a thin layer of tissue (pseudomembrane) from the back of the nose using a scope can prevent radiation-induced tissue death in patients with recurrent nasopharyngeal cancer who have had repeat radiation. About 40 adults in China will undergo the p…
Phase: NA • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:24 UTC
-
Herbal mouthwash may stop radiation mouth sores before they start
Prevention Not yet recruitingThis study tests whether a modified herbal mouthwash can prevent painful mouth sores caused by radiation therapy in people with head and neck cancer. About 156 participants will use either the herbal mouthwash or a placebo during their radiation treatment. The goal is to see if t…
Phase: PHASE3 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Fish oil fights flu? new study tests Omega-3 against winter bugs
Prevention Not yet recruitingThis study tests whether a special fish oil (Omega Cold) can help healthy adults avoid or recover faster from colds, flu, and COVID-19. Four hundred participants aged 18–80 will take either the fish oil or a placebo daily for four months during flu season. They will report any sy…
Phase: NA • Sponsor: Landspitali University Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:08 UTC
-
Simple nasal spray may prevent hearing loss in cancer survivors
Prevention Not yet recruitingThis study tests whether a steroid nasal spray can prevent fluid buildup in the middle ear, a common side effect of radiation therapy for nasopharyngeal cancer. About 168 adults who are about to start radiation will use either the spray or a placebo for 12 months. The goal is to …
Phase: PHASE3 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Prevention
Last updated Jun 27, 2026 07:52 UTC
-
New injection could tame teen hay fever
Symptom relief Not yet recruitingThis study tests whether an injection called stapokibart can reduce nasal allergy symptoms like runny nose, congestion, sneezing, and itching in adolescents aged 12 to 17 with seasonal allergic rhinitis (hay fever). Participants receive either stapokibart or a placebo alongside t…
Phase: PHASE3 • Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Acupuncture timing may be key to preventing dry mouth in head and neck cancer patients
Symptom relief Not yet recruitingThis trial compares early versus delayed acupuncture to reduce dry mouth caused by chemoradiation in head and neck cancer patients. Participants receive acupuncture either during chemoradiation or after, and their dry mouth symptoms are tracked for a year. The goal is to find the…
Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Herbal hope: new blend aims to shorten your next cold
Symptom relief Not yet recruitingThis study tests a new herbal blend designed to shorten the duration and reduce the severity of common cold symptoms. Researchers will enroll 300 healthy adults in Australia who get frequent colds. Participants will take the herbal product or a placebo whenever they feel a cold c…
Phase: PHASE2 • Sponsor: RDC Clinical Pty Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Hands-On therapy may spare kids from ear tube surgery
Symptom relief Not yet recruitingThis study tests whether osteopathic manipulative treatment (OMT) — a gentle, hands-on therapy — can reduce the need for ear tube surgery in children with chronic or recurrent ear infections. Two hundred children aged 6 months to 7 years will receive either OMT or a placebo manua…
Phase: NA • Sponsor: Sarah Vidal • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New syrup aims to soothe coughs in just two days
Symptom relief Not yet recruitingThis study looks at how well and how safely SIROPSEDAL syrup works for acute cough caused by colds or upper respiratory infections. About 124 children and adults will take the syrup as prescribed by their doctor and report their cough severity over one week. The main goal is to s…
Sponsor: Laboratoires Elerte • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New shot for teen hay fever? early trial underway
Symptom relief Not yet recruitingThis phase 2 trial tests the safety of stapokibart injection in 15 teenagers aged 12-17 with seasonal allergic rhinitis (hay fever). Participants receive the drug alongside their usual allergy treatments. The study focuses on side effects and how the body processes the drug, not …
Phase: PHASE2 • Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New nasal spray aims to unblock stuffy noses fast
Symptom relief Not yet recruitingThis study looks at how well RHINOSEDAL works for people aged 8 and older with a stuffy nose caused by colds, allergies, or sinus issues. About 126 participants will use the treatment as prescribed and report their symptoms over 6 days. The goal is to see if it provides meaningfu…
Sponsor: Laboratoires Elerte • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Virtual reality could replace pills for pain during ENT procedures
Symptom relief Not yet recruitingThis study compares two types of virtual reality (VR) during common ear, nose, and throat (ENT) procedures. One group will watch calming scenery, while the other plays an interactive puzzle game. Researchers want to see which better reduces pain and anxiety. The study will includ…
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New allergy spray trial aims to help teens breathe easier
Symptom relief Not yet recruitingThis study tests if Dymista nasal spray safely eases allergy symptoms like sneezing, stuffy nose, and itchy eyes in Chinese teenagers aged 12 to 17. About 100 participants will use the spray twice daily for two weeks. The goal is to see if symptoms improve, not to cure allergies.
Phase: PHASE4 • Sponsor: Viatris Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Partial tonsil surgery may cut sick leave and opioid use
Symptom relief Not yet recruitingThis study compares two tonsil surgery methods in adults: full removal (extracapsular) and partial removal (intracapsular). The goal is to see if partial surgery allows a shorter sick leave and less need for opioid painkillers, while still being as effective at relieving tonsilli…
Phase: NA • Sponsor: Turku University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New allergy blocker spray could offer Drug-Free relief
Symptom relief Not yet recruitingThis study tests a new nasal spray called PL-14 Allergy Blocker in about 120 adults with seasonal allergies. Unlike regular allergy sprays, PL-14 is drug-free and works by forming a gel-like barrier in the nose to block allergens. The study compares it to a simple saline spray ov…
Phase: NA • Sponsor: Polyrizon Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Bee venom zaps sinus pain? new trial tests sting therapy
Symptom relief Not yet recruitingThis study tests whether applying bee venom to the face using ultrasound can ease chronic sinusitis symptoms. Thirty adults with sinusitis will either get bee venom phonophoresis or standard care (decongestants and saline rinses). Researchers will measure changes in symptom sever…
Phase: NA • Sponsor: Sinai University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New devices aim to soothe sore throats without drugs
Symptom relief Not yet recruitingThis study will test four medical devices (HMG, PHN, PHR, TUR) in 160 adults with sore throat from acute pharyngitis or viral tonsillitis. The goal is to see if they are safe and help reduce symptoms like pain when swallowing. Participants will use the device for up to 7 days and…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Water workout could soothe chronic dizziness
Symptom relief Not yet recruitingThis study tests whether Ai Chi, a slow, controlled water exercise program, can help people with long-term dizziness from inner ear problems. 38 adults will either do standard home exercises or add Ai Chi sessions in a pool over 4 weeks. Researchers will measure changes in balanc…
Phase: NA • Sponsor: Gaziosmanpasa Research and Education Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New gel promises Ultra-Fast relief for chronic throat and nose sufferers
Symptom relief Not yet recruitingThis study is testing a special gel made from hyaluronan (a natural substance) to see if it can quickly ease discomfort in the throat and nose for people with chronic rhinitis and pharyngitis. Thirty adults with these conditions will use the gel twice daily for 10 days. The main …
Phase: NA • Sponsor: Nakhia Impex LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Simple eye exercises may soothe motion sickness and vertigo
Symptom relief Not yet recruitingThis study tests whether special eye and balance exercises can reduce dizziness, motion sickness, and improve quality of life in people with inner-ear balance problems. Thirty-two adults with motion sickness or vertigo will do either standard habituation exercises or a new optoki…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New surgical wrap aims to cut palate injuries in half
Symptom relief Not yet recruitingThis study compares two ways to lift the soft palate during throat surgery to see which causes fewer injuries. About 138 people aged 2 to 70 who need this type of surgery will be randomly assigned to either the standard double-strap method or a new full-wrap method. The goal is t…
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Taurine: a simple supplement to fight radiation mouth sores?
Symptom relief Not yet recruitingThis phase 2 trial tests whether taking taurine (a common amino acid) can prevent or reduce severe mouth sores caused by radiation therapy in people with nasopharyngeal cancer. 130 patients will take taurine pills or receive standard care starting 3 days before radiation until 1 …
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
One-Hour talk may quiet the world for Sound-Sensitive patients
Symptom relief Not yet recruitingThis study tests whether a single one-hour educational session with an audiologist can help people with hyperacusis (extreme sensitivity to sound) feel more comfortable around everyday noises. Five participants will track their sound exposure and sensitivity for one month using a…
Phase: NA • Sponsor: University Hospital, Antwerp • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Ancient heat therapy tested for allergy relief
Symptom relief Not yet recruitingThis study tests whether adding moxibustion—a traditional heat therapy—to standard allergy medicine can safely reduce symptoms like sneezing, stuffiness, and runny nose in people with allergic rhinitis. About 60 adults with a cold-type allergy will receive either standard care al…
Phase: NA • Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Surgery vs. meds: new study tests best way to treat Kids' allergies
Symptom relief Not yet recruitingThis study looks at whether removing the adenoids (with or without tonsils) can improve allergy symptoms in children aged 3 to 12 who also have enlarged adenoids and tonsils. Researchers will compare surgery to standard medication by tracking symptom scores and allergy markers in…
Phase: NA • Sponsor: Tongji Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Which allergy med combo works best? new study aims to find out
Symptom relief Not yet recruitingThis study compares two common treatment combinations for allergic rhinitis (hay fever) in adults: a nasal steroid spray plus an oral antihistamine versus a nasal steroid spray plus an oral antileukotriene. The goal is to see which combo better relieves symptoms like sneezing, st…
Phase: PHASE4 • Sponsor: Liaquat National Hospital & Medical College • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Could a sleep apnea machine help people with collapsed airways?
Symptom relief Not yet recruitingThis study looks at whether CPAP, a machine that pushes air through a mask at night, can help people with large airway collapse (LAC). LAC causes shortness of breath, cough, and wheeze, and is often mistaken for asthma. The study will test if a larger trial is possible by checkin…
Phase: NA • Sponsor: Liverpool School of Tropical Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Could a simple pillow ease Kids' pain and worry after surgery?
Symptom relief Not yet recruitingThis study looks at whether a special pillow that combines cold therapy and arm elevation can help children aged 7 to 12 feel less anxious and more comfortable after surgery for a broken arm. About 80 kids will be randomly assigned to use either the special pillow or standard car…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Can a blood injection restore lost smell? new study aims to find out
Symptom relief Not yet recruitingThis study tests whether injecting a person's own platelet-rich plasma (PRP) into the nose can help restore smell in adults who have had smell loss for more than 6 months due to aging or head injury. Thirty participants will receive three PRP injections over four weeks and be fol…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New allergy shot under safety spotlight
Symptom relief Not yet recruitingThis study will test the safety of a new biologic drug called stapokibart, given as a shot, in 400 adults with seasonal allergic rhinitis (SAR). Participants are already prescribed the drug by their doctor. The main goal is to track any side effects. This is an open-label study, …
Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New shot could quiet constant sniffles for months
Symptom relief Not yet recruitingThis study tests an injection called JYB1904 for people with year-round allergies (perennial allergic rhinitis). The goal is to see if it can reduce symptoms like runny nose, congestion, and sneezing better than a placebo. About 135 adults who already use nasal sprays will receiv…
Phase: PHASE2 • Sponsor: Jemincare • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could a migraine drug stop dizziness fast?
Symptom relief Not yet recruitingThis study tests whether rimegepant, a drug used for migraines, can quickly reduce dizziness from conditions like vestibular migraine. About 370 adults with moderate to severe dizziness will receive either rimegepant plus betahistine or betahistine alone. The main goal is to see …
Phase: PHASE2, PHASE3 • Sponsor: Shi Tianming • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New allergy drug AK139 aims to stop sneezing and stuffy noses
Symptom relief Not yet recruitingThis study tests a new medicine called AK139 for people with moderate to severe seasonal allergic rhinitis (hay fever). About 111 adults aged 18-65 with at least a 2-year history of seasonal allergies will receive either AK139 or a placebo. The main goal is to see if AK139 reduce…
Phase: PHASE2 • Sponsor: Akeso • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New beam angle may spare cancer patients from dry mouth and swallowing woes
Symptom relief Not yet recruitingThis study tests whether a new way of aiming radiation beams (non-coplanar) can reduce side effects like dry mouth and swallowing problems in people with head and neck cancer. About 70 adults with cancer of the mouth or throat will be randomly assigned to standard or new radiatio…
Phase: NA • Sponsor: Centre Georges Francois Leclerc • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Could less radiation be just as effective for HPV throat cancer?
Symptom relief Not yet recruitingThis study is for people with HPV-related oropharyngeal (throat) cancer, which often responds well to treatment. The goal is to see if lowering the radiation dose to certain areas can reduce side effects like dry mouth without hurting the chance of curing the cancer. About 132 pa…
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Can insulin plus platelet-rich plasma bring back your sense of smell?
Symptom relief Not yet recruitingThis study tests whether adding insulin to a platelet-rich plasma (PRP) treatment helps adults who lost their sense of smell after an infection. Twenty participants will be randomly assigned to receive either PRP alone or PRP plus insulin. Their ability to smell will be measured …
Phase: NA • Sponsor: Amin Javer • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New nose drop study aims to bring back lost smell for sinusitis sufferers
Symptom relief Not yet recruitingThis study compares two ways to give steroid medicine to people with chronic sinusitis who have lost their sense of smell due to blocked nasal passages. One group will get standard steroid spray, while the other gets steroid drops placed directly where smell happens. The goal is …
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Smell training gets a boost: steroid drops show promise for Post-Infection smell loss
Symptom relief Not yet recruitingThis study tests whether adding steroid nasal drops to standard smell training can improve smell function in people who lost their sense of smell after an infection (like a cold or COVID-19). 100 adults with impaired smell will receive either steroid drops plus training or placeb…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Can a single pill stop post-surgery sickness? new ear surgery trial aims to find out.
Symptom relief Not yet recruitingThis study tests whether the drug aprepitant can reduce nausea and vomiting after ear surgery. About 100 adults having middle ear procedures will be randomly assigned to receive the drug or a placebo. The goal is to see if it improves recovery comfort.
Phase: PHASE4 • Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Robot vs. surgeon: which cochlear implant method gives better hearing?
Symptom relief Not yet recruitingThis study compares two ways to insert a cochlear implant: using a robotic device or the standard manual method. Researchers want to see which approach leads to better hearing one year after surgery. The study will enroll 32 adults with hearing loss, randomly assigning them to on…
Phase: NA • Sponsor: AdventHealth • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Could hydrogen water soothe mouth pain after oral cancer surgery?
Symptom relief Not yet recruitingThis study tests whether rinsing with hydrogen water can reduce mouth inflammation and pain in people recovering from oral cancer surgery that used a free flap reconstruction. Thirty-six participants will use hydrogen water or plain water for oral care over 7 days. Researchers wi…
Phase: NA • Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Which allergy med combo works best? new study aims to find out
Symptom relief Not yet recruitingThis study compares two ways to treat moderate to severe allergic rhinitis: using a nasal steroid spray plus an antihistamine nasal spray versus the same steroid spray plus an antihistamine pill. Fifty people aged 12 to 75 will be randomly assigned to one of the two treatments fo…
Phase: PHASE4 • Sponsor: China-Japan Union Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New pain block could spare kids opioids after tonsil surgery
Symptom relief Not yet recruitingThis study tests whether a nerve block (injecting numbing medicine near the cheekbone) can control pain after tonsillectomy in children aged 3-9, reducing the need for opioids. Sixty kids having tonsil surgery for sleep apnea will be randomly assigned to get either the nerve bloc…
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Could a simple nerve block replace opioids for Children's ear surgery pain?
Symptom relief Not yet recruitingThis study compares a nerve block (injecting numbing medicine near the ear) to standard painkillers (fentanyl and ketorolac) for children aged 6 months to 6 years having ear tube surgery. The goal is to see if the nerve block works just as well for pain control, with fewer side e…
Phase: PHASE4 • Sponsor: University of South Alabama • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New nebulizer may ease chronic sinusitis symptoms
Symptom relief Not yet recruitingThis study tests if a nebulized steroid (budesonide) delivered via the NasoNeb device is safe and effective for chronic rhinosinusitis. 50 adults with the condition will be randomly assigned to receive either nebulized budesonide or a standard steroid lavage. The main goal is to …
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
New allergy shot strategy aims to stop sneezing and sniffling for good
Symptom relief Not yet recruitingThis study tests whether giving extra booster shots of allergy medicine directly into the tonsils can better control hay fever symptoms. About 276 adults with allergic rhinitis will receive either the standard three doses or additional boosters. Researchers will track symptom rel…
Phase: NA • Sponsor: Renmin Hospital of Wuhan University • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Can a simple drug stop Kids' surgery agitation?
Symptom relief Not yet recruitingThis study tests whether propofol or lidocaine, given right after surgery, can reduce agitation when children wake up from tonsillectomy. Eighty-two children aged 4 to 7 will be randomly assigned to receive one of the two drugs. The goal is to find a safer, more comfortable recov…
Phase: PHASE4 • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Can salt water clear your Baby's stuffy nose? new study aims to find out
Symptom relief Not yet recruitingThis study looks at how well a saltwater (saline) nasal spray works and how safe it is for infants and toddlers aged 3 months to 4 years with stuffy noses from colds, flu, or allergies. About 83 children will use the spray for up to 14 days, and parents will report symptom change…
Sponsor: Laboratoires Quinton International S.L. • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New hope for chronic face pain: lidocaine and ketamine combo tested
Symptom relief Not yet recruitingThis study compares two pain-relieving drugs, lidocaine and ketamine, given through an IV, to see if they can reduce stubborn face or mouth pain. About 105 adults with pain that hasn't responded to other treatments will receive one or both drugs. The goal is to measure pain relie…
Phase: PHASE2 • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Sound therapy offers hope for empty nose sufferers
Symptom relief Not yet recruitingThis study tests if Acoustic Resonance Therapy (ART) can relieve symptoms of Empty Nose Syndrome (ENS), a condition where past nose surgery leaves patients feeling blocked despite open airways. ART uses sound vibrations to clear mucus and reduce inflammation. About 40 adults with…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New study aims to stop coughing after sinus surgery
Symptom relief Not yet recruitingThis study tests whether adding magnesium sulfate or lidocaine to a standard sedative (dexmedetomidine) better prevents coughing after functional endoscopic sinus surgery. Coughing after this surgery can cause bleeding and slow recovery. About 102 adults will be randomly assigned…
Phase: PHASE3 • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New shot could tame hay fever misery
Symptom relief Not yet recruitingThis study tests an injection called GR1802, given alongside usual allergy treatments, to see if it can better control symptoms like sneezing, runny nose, and itchy eyes in people with seasonal allergic rhinitis (hay fever). About 144 adults who have had poor symptom control with…
Phase: PHASE3 • Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Can a natural spray beat dust mite allergies? new study aims to find out
Symptom relief Not yet recruitingThis study tests whether a natural nasal spray (Puressentiel Allergy Protection) can reduce symptoms of dust mite allergies. Twenty adults with dust mite allergic rhinitis will receive either the spray or a saline placebo before a nasal allergen challenge. Researchers will measur…
Phase: NA • Sponsor: Puressentiel • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Asthma drug could stop cat allergy sneezes in their tracks
Symptom relief Not yet recruitingThis small Phase 2 trial tests whether a single dose of zafirlukast, an asthma drug, can prevent nasal symptoms caused by cat dander. Twelve adults with cat allergies will receive either the drug or a placebo before being exposed to cat dander in a controlled setting. Their sympt…
Phase: PHASE2 • Sponsor: Allergy & Asthma Medical Group & Research Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Nose reconstruction or prosthesis? study aims to settle the debate
Knowledge-focused Not yet recruitingThis study compares two ways to rebuild the nose after partial or total loss: surgery using skin flaps, or a custom-made prosthetic nose (epithesis). Researchers will ask people who had either treatment at least one year ago to fill out a questionnaire about how their nose looks …
Sponsor: Hôpital NOVO • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Can your balance predict motion sickness? new study investigates
Knowledge-focused Not yet recruitingThis study will measure balance, coordination, and reaction time in 41 adults aged 18-40 who experience motion sickness. Participants will complete a series of physical tests and a controlled motion sickness provocation session. The goal is to see how these sensorimotor skills re…
Sponsor: Istinye University • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Blood test may reveal if allergy treatment is effective
Knowledge-focused Not yet recruitingThis study aims to develop a blood test that measures B regulatory cells, which may indicate whether allergen immunotherapy (allergy shots) is successfully reducing allergic reactions. Researchers will study 80 adults with pollen or venom allergies who are starting routine allerg…
Sponsor: Hull University Teaching Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Greek sinusitis study aims to personalize treatment by analyzing inflammation
Knowledge-focused Not yet recruitingThis study will collect and analyze nasal tissue from 230 Greek patients with chronic sinusitis (with or without nasal polyps) to identify different inflammation patterns, called endotypes. By understanding these patterns, researchers hope to better match patients with the most e…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Rare bone infection study aims to uncover best treatment paths
Knowledge-focused Not yet recruitingThis study follows 100 adults diagnosed with skull base osteomyelitis, a rare and serious bone infection near the ear and skull base. Researchers will track how often the infection returns or leads to death within 12 months. The goal is to gather real-world data to help standardi…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Parents as ear infection detectives: new study tests home otoscopy
Knowledge-focused Not yet recruitingThis pilot study will test if parents can learn to use a digital otoscope (ear camera) at home to check for ear infections in their young children. About 40 children aged 1-4 who have had ear infections before will take part. Parents in the study group will get training and a dev…
Phase: NA • Sponsor: Turku University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
France launches massive virus surveillance in GP clinics
Knowledge-focused Not yet recruitingThis study will track which respiratory viruses—like flu, COVID-19, and RSV—are circulating in French primary care clinics each winter. Up to 25,000 patients with cold or flu symptoms will provide a saliva or nose swab sample. The goal is to monitor virus activity and help guide …
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
AI to predict cancer risk from gut bacteria and scans
Knowledge-focused Not yet recruitingThis study will collect data from 10,000 people undergoing upper endoscopy to build an AI model that predicts the risk of developing stomach or esophageal cancer. Researchers will combine information from endoscopy images, tissue samples, genetics, and gut bacteria. Participants …
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Scientists map cell types in oral cancer to unlock early detection
Knowledge-focused Not yet recruitingThis study aims to understand the different cell types in oral cancer and pre-cancerous mouth lesions. Researchers will analyze tissue and blood samples from 150 participants to map gene activity and cell interactions. They will also test whether a simple brush sample can replace…
Phase: NA • Sponsor: Centre Leon Berard • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New ultrasound score may better monitor rare artery disease
Knowledge-focused Not yet recruitingThis study will test whether a special ultrasound score, called OTUS, can accurately track disease activity in people with Takayasu arteritis, a rare condition that causes inflammation of the large arteries. Researchers will follow 100 patients with active disease, performing ult…
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Researchers check safety of stent grafts used in aortic aneurysm surgery
Knowledge-focused Not yet recruitingThis study looks back at medical records of 105 people who had a minimally invasive surgery called BEVAR to treat complex aortic aneurysms. Researchers want to see if two types of stent grafts (TUVA BX and iCover) are safe and work well. No new treatments are given; the study jus…
Sponsor: JOTEC GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
AI tool aims to spot head and neck cancer risk early
Knowledge-focused Not yet recruitingThis study will use artificial intelligence to create a risk prediction model for head and neck cancers, including cancers of the throat and voice box. Researchers will collect data from 3000 participants, including their medical history, lifestyle habits, and laryngoscopy images…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Tiny study aims to unravel mysteries of stuffy nose disease
Knowledge-focused Not yet recruitingThis study looks at chronic sinusitis with nasal polyps, a condition causing long-term nasal congestion and breathing problems. Researchers will measure inflammation markers and examine nasal tissue from 10 adults using a steroid spray (budesonide). The goal is to better understa…
Phase: NA • Sponsor: St. Paul's Sinus Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Could a simple mucus test transform nasal polyp treatment?
Knowledge-focused Not yet recruitingThis study looks at whether measuring the thickness (viscosity) of nasal mucus can help doctors better understand the type of inflammation in people with chronic sinusitis and nasal polyps. Researchers will compare mucus from 60 patients having sinus surgery—some with polyps and …
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Dye technique could spare neck surgery for head and neck cancer patients
Knowledge-focused Not yet recruitingThis study tests whether injecting two dyes around the tumor and into cancerous lymph nodes can help surgeons spot hidden cancer spread in head and neck cancer. Twenty adults with oral cavity or head and neck skin cancer will receive the dyes before surgery. The goal is to see if…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
MRI reveals hidden speech success after late cleft palate repair
Knowledge-focused Not yet recruitingThis study will use MRI scans to see how well the palate and throat muscles work after a special surgery for cleft palate repair. The surgery uses a piece of cheek muscle to close the gap and aims to improve speech. Ten people who have not had early treatment will get the surgery…
Phase: NA • Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Kids with cancer share secrets to eating well despite chemo's taste and smell side effects
Knowledge-focused Not yet recruitingThis study will interview 30 children aged 6-17 who are undergoing chemotherapy for cancer, along with their parents, to understand how they deal with changes in taste, smell, and food texture. The goal is to learn what coping strategies families use at home and in the hospital t…
Sponsor: Centre Leon Berard • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Jaw surgery for sleep apnea may cause temporary speech issues, study finds
Knowledge-focused Not yet recruitingThis study looks at how often people develop speech or swallowing problems after a jaw-advancement surgery for obstructive sleep apnea. Researchers will measure nasality, speech, and swallowing in 28 adults before and after surgery at five different times. The goal is to better u…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Which ear gets the implant? new study aims to reduce dizziness
Knowledge-focused Not yet recruitingThis study looks at 10 adults over 50 with hearing loss and one weak balance ear. It compares implanting the device in the weak-balance ear versus the good-balance ear. The goal is to see if choosing the weaker side helps reduce dizziness after surgery.
Phase: NA • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New monitor may predict heart danger during nose surgery
Knowledge-focused Not yet recruitingThis study tests whether a device called the Analgesia Nociception Index (ANI) can predict and prevent a sudden drop in heart rate (trigeminal cardiac reflex) during nasal septoplasty. 90 adults undergoing nose surgery will be monitored either with standard tools or with the ANI …
Sponsor: Fayoum University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Caffeine timing may boost gym gains, new study suggests
Knowledge-focused Not yet recruitingThis study looks at how taking caffeine in different ways—daily low doses, gradually increasing doses, or only on workout days—affects muscle growth and strength in 180 young men who don't normally drink caffeine or exercise with weights. Participants will follow two 4-week super…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New digital health tool aims to simplify care for patients with multiple chronic illnesses
Knowledge-focused Not yet recruitingThis study tests a new digital health tool designed to help adults aged 40 and older who have two or more long-term health conditions, like high blood pressure, diabetes, or depression. The tool includes an electronic system to guide doctors, telemedicine for specialist visits, a…
Sponsor: Centre for Chronic Disease Control, India • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New study aims to find best treatment path for tough nasopharyngeal cancers
Knowledge-focused Not yet recruitingThis study looks at patients with a type of throat cancer (nasopharyngeal carcinoma) whose tumors did not shrink after two rounds of chemotherapy. It compares two different next steps: switching to a different chemotherapy combination before radiation, or going straight to radiat…
Sponsor: Fujian Cancer Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New CT scoring aims to better detect smell loss in allergy patients
Knowledge-focused Not yet recruitingThis study will test a new way to score CT scans to see how well it measures smell loss in people with central compartment atopic disease (CCAD), a type of nasal allergy. Researchers will compare the new scoring system to the traditional one in 120 participants. The goal is to im…
Sponsor: Peking University Third Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
New study aims to unlock clues in nasopharyngeal cancer
Knowledge-focused Not yet recruitingThis study looks for biological markers in people with nasopharyngeal carcinoma to help predict how the disease will progress and how well treatments might work. Researchers will analyze tissue samples from 60 newly diagnosed patients who have not had their cancer spread. The goa…
Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
AI takes on air pollution: can it help europe breathe easier?
Knowledge-focused Not yet recruitingThis study uses artificial intelligence to understand how air pollution and climate change impact respiratory diseases like allergic rhinitis and asthma. Researchers will gather health data from about 1,900 patients across Europe and analyze it with AI tools to find better ways t…
Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Can scans and DNA predict cancer treatment success?
Knowledge-focused Not yet recruitingThis study aims to better predict how head and neck cancer responds to chemoradiotherapy. Researchers will use MRI, PET/CT scans, and blood/tumor DNA tests from 152 patients to build a combined prediction model. The goal is to identify which patients have a complete response with…
Phase: NA • Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
New asthma drug formulation put to the test in healthy adults
Knowledge-focused Not yet recruitingThis study compares two oral formulations of pranlukast, a drug used for asthma and allergic rhinitis, to see if they are equivalent. Sixty healthy adults will receive a single dose of each version in random order under fasting conditions. The main goal is to measure drug levels …
Phase: PHASE1 • Sponsor: AJU Pharm Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Neglected sense: study tests if smell checks boost health
Knowledge-focused Not yet recruitingThis study looks at whether helping people who have trouble smelling can improve their health and happiness. Many people don't realize their sense of smell is fading, which can affect mood, nutrition, and even safety. Researchers will give smell tests and coping advice to 1000 ad…
Phase: PHASE2 • Sponsor: Monell Chemical Senses Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
CT scans reveal hidden link between nose shape and sinus trouble
Knowledge-focused Not yet recruitingThis study uses CT scans to see how a deviated nasal septum (a crooked wall inside the nose) affects the size of the maxillary sinuses and the chance of developing sinusitis. Researchers will compare the deviated side to the normal side in 120 adults. The goal is to better unders…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
New study aims to unlock immune secrets of nasopharyngeal cancer
Knowledge-focused Not yet recruitingThis study will look at tissue samples from 600 people with nasopharyngeal carcinoma to understand how the tumor's immune environment changes over time. The goal is to find markers that predict how well immunotherapy will work and to identify new treatment targets. Participants m…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Could new scans revolutionize nasopharyngeal cancer care?
Knowledge-focused Not yet recruitingThis observational study will test whether two new types of PET/CT scans can more accurately stage nasopharyngeal carcinoma and predict how well patients respond to immunotherapy before treatment. About 732 participants aged 18-70 with newly diagnosed, untreated cancer will recei…
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:41 UTC